MedTrace Logo

DNA Repair and Genetic Susceptibility to Lung Cancer

NCT00611598 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 218

Last updated 2023-03-29

No results posted yet for this study

Summary

The purpose of this study is to help us better understand the cellular changes that may lead to the development of lung cancer. We want to compare people with a second primary lung cancer with those who have only a first primary lung cancer. We hope to use the information obtained in this study as the basis for future studies and will not regard the results from this study as final.

We will analyze your blood cells and DNA to measure the changes in several genes that we believe may be involved in lung cancer. We also want to evaluate the capacity for your DNA to repair itself.

Conditions

  • Lung Cancer
  • Single Primary Lung Cancer
  • Second Primary Lung Cancer

Interventions

OTHER

Blood draw and Questionnaires

Pt will have three green top tubes of blood drawn. The questionnaire will be filled out by the study subject. This may be completed at home and mailed in a provided stamped addressed envelope if the patient prefer, or obtained by phone interview with a research assistant.

OTHER

Blood draw and Questionnaires

Pt will have three green top tubes of blood drawn. The questionnaire will be filled out by the study subject. This may be completed at home and mailed in a provided stamped addressed envelope if the patient prefer, or obtained by phone interview with a research assistant.

Sponsors & Collaborators

Principal Investigators

  • Irene Orlow, PhD · Memorial Sloan Kettering Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-02-11
Primary Completion
2023-03-24
Completion
2023-03-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00611598 on ClinicalTrials.gov